Suppression of sensory C fiber-mediated contractions by neuropeptide Y Y1 receptors in the guinea pig bronchi

Regulatory Peptides

Volumn 75-76, Issue , 1998, Pages 181-184

  Grundemar, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Airways; Electrical field stimulation; Guinea pig; Neuropeptide Y; Neuropeptide Y receptor antagonist; Neuropeptide Y receptors; Pancreatic polypeptide; Peptide YY; Sensory C fiber

Indexed keywords

NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; PEPTIDE YY; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CONTROLLED STUDY; DOSE RESPONSE; GUINEA PIG; IN VITRO STUDY; NERVE FIBER C; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARGININE; BRONCHI; BRONCHOCONSTRICTION; GUINEA PIGS; HUMANS; NERVE FIBERS; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PEPTIDE YY; RECEPTORS, NEUROPEPTIDE Y;

CAVIA PORCELLUS; SUS SCROFA;

EID: 4243375137     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(98)00066-4     Document Type: Article

References (30)

1. Sundler F., Håkanson R., Ekblad B., Uddman R., Wahlestedt C. Neuropeptide Y in peripheral and enteric nervous systems. Ann Rev Cytol. 102:1986;234-269.
2. Uddman R., Sundler F., Emson P. Occurrence and distribution of neuropeptide Y immunoreactive nerves in the respiratory tract and middle ear. Cell Tiss Res. 237:1984;321-327.
3. Grundemar L., Grundström N., Andersson R.G.G., Johansson I., Håkanson R. Suppression by neuropeptide Y of capsaicin-sensitive sensory nerve-mediated contraction in guinea pig airways. Br J Pharmacol. 99:1990;473-476.
4. Grundemar L., Wahlestedt C., Wang Z.-Y. Neuropeptide Y suppresses the neurogenic inflammatory response in the rabbit eye; mode of action. Regul Pept. 43:1993;57-64.
5. Grundemar L. Multiple receptors and multiple actions. In: Grundemar L, Bloom SR, editors. Neuropeptide Y and Drug Development.London: Academic Press, 1997:1-14.
6. Grundemar L., Krstenansky J.L., Håkanson R. Activation of Y1 and Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes. Eur J Pharmacol. 232:1993;271-278.
7. Grundemar L., Mörner S.E.J.M., Högestatt E.D., Wahlestedt C., Håkanson R. Characterization of vascular neuropeptide Y receptors. Br J Pharmacol. 105:1992;45-50.
8. Grundemar L., Håkanson R. Effects of various neuropeptide Y/peptide YY fragments on electrically-evoked contractions of the rat vas deferens. Br J Pharmacol. 100:1990;190-192.
9. Lacroix J.S., Ulman L.G., Potter E.K. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilation via Y2 prejunctional receptor. Br J Pharmacol. 113:1994;479-484.
10. Hirabayashi A., Nishiwaki K., Shimada Y., Ishikawa N. Role of neuropeptide Y and its receptor subtypes in neurogenic pulmonary edema. Eur J Pharmacol. 296:1996;297-305.
11. Bischoff A., Avramidis P., Erdbrugger W., Munter K., Michel M.C. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y. Br J Pharmacol. 120:1997;1335-1343.
12. Lundell I., Blomqvist A.G., Berglund M.M., Schober D.A., Johnson D., Statnik M.A., Gadski R.A., Gehlert D.R., Larhammar D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem. 270:1995;29123-29128.
13. Gerald C., Walker M.W., Criscione L., Gustavson E.L., Batzl-Hartmann C., Smith K.B., Vaysee P.J.J., Durkin M.M., Laz T.M., Linemeyer D., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide Y-induced feeding. Nature (London). 382:1996;168-171.
14. Gregor P., Feng Y., DeCarr L.B., Cornfield U., McCaleb M.L. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J Biol Chem. 271:1996;27776-27781.
15. Szolcsanyi J., Barthó L. Capsaicin-sensitive non-cholinergic excitatory mnnervatin of the guinea pig tracheobronchial smooth muscle. Neurosci Lett. 34:1982;247-251.
16. Cadieux A., Benchekroun M.T., St-Pierre S., Fournier A. Bronchoconstrictor action of neuropeptide Y (NPY) in isolated guinea pig airways. Neuropeptides. 13:1989;215-219.
17. Belvisi M.G., Stretton D., Barnes P.J. Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig trachea. Eur J Pharmacol. 198:1991;219-221.
18. Rudolf K., Eberlein W., Engel W., Wieland H.A., Willim K.D., Entzeroth M., Wienen W., Beck-Sickinger A.-G., Doods U.N. The first highly potent and selective non-peptide neuropeptide Y Yl receptor antagonist BIBP3226. Eur J Pharmacol. 271:1994;R11-R13.
19. Leander S., Grundström N., Andersson R.G.G., Håkanson R. Neurally mediated non cholinergic contractions of guinea pig bronchial smooth muscle is inhibited by a SP-antagonist. Agents Actions. 14:1984;315-318.
20. McAuley M.A., Westfall T.C. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed. J Pharmacol Exp Ther. 261:1992;863-868.
21. Grundemar L., Widmark B., Waldeck B., Håkanson R. Neuropeptide Y: prejunctional inhibition of vagally induced contractions in the guinea pig trachea. Regul Pept. 23:1998;309-313.
22. Potter B.K., Michell L., McCloskey M.D.J., Tseng A., Goodman A.B., Shine J., McCloskey D.I. Pre-and postjunctional actions of neuropeptide Y and related peptides. Regul Pept. 25:1989;165-177.
23. Grundemar L. Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea. Regul. Pept. 71:1997;97-101.
24. Grundemar L., Ekelund M. Effects of the neuropeptide Y (NPY)-receptor antagonist BIBP3226 on vascular NPY receptors with different ligand requirements. Pharmacol Toxicol. 79:1996;266-269.
25. Larhammar D., Blomqvist A.G., Yee F., Jazin B., Yoo H., Wahlestedt C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem. 267:1992;10935-10938.
26. Sharma P., Berglund M.M., Holmberg S., Briksson H., Grundemar L., Larhammar D. Cloning and characterization of guinea pig Y1 and Y2 receptor types. Regul Pept. 71:1997;P7.
27. Grundemar L., Wahlestedt C., Reis D.J. Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. J Pharmacol Exp Ther. 258:1990;633-638.
28. Glaum S.R., Miller R.J., Rhim H., Maclean D., Georgic L.M., MacKenzie R.G., Grundemar L. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Ypeptide YY peptides in the rat brainstem. Br J Pharmacol. 120:1997;481-487.
29. Larhammar D Extraordinary structural diversity of NPY family of receptors. In: Grundemar L, Bloom SR, editors. Neuropeptide Y and Drug Development. London: Academic Press, 1997:87-105.
30. 34]Neuropeptide Y: a specific Y1 receptor agonist. Proc Natl Acad Sci USA, 187:1990;182-186.